Godavari Drugs Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 395.43 million compared to INR 405.47 million a year ago. Revenue was INR 395.46 million compared to INR 406.79 million a year ago. Net income was INR 8.56 million compared to INR 8.64 million a year ago. Basic earnings per share from continuing operations was INR 1.14 compared to INR 1.15 a year ago. Diluted earnings per share from continuing operations was INR 1.14 compared to INR 1.15 a year ago.
For the six months, sales was INR 749.61 million compared to INR 830.97 million a year ago. Revenue was INR 754.17 million compared to INR 832.96 million a year ago. Net income was INR 16.66 million compared to INR 17.86 million a year ago. Basic earnings per share from continuing operations was INR 2.21 compared to INR 2.37 a year ago. Diluted earnings per share from continuing operations was INR 2.21 compared to INR 2.37 a year ago.